Cory Berkland

Mark and Becky Levin Professor in the Departments of Biomedical Engineering and Chemistry

Cory Berkland is the Mark and Becky Levin Professor in the Departments of Biomedical Engineering and Chemistry at Washington University in Saint Louis. Previously, he was the Solon E. Summerfield Professor in the Department of Pharmaceutical Chemistry and in the Department of Chemical Engineering at The University of Kansas. He received MS and PhD degrees from the Department of Chemical and Biomolecular Engineering at the University of Illinois in Urbana-Champaign and a BS degree in Chemical Engineering from Iowa State University in Ames. His lab studies pharmaceuticals and materials with an emphasis on molecular design and transport in the human body, and more recently, wearable technologies. He is a co-founder of Orbis Biosciences (acquired by Adare Pharmaceuticals), Savara Pharmaceuticals (NASDAQ:SVRA), Bond Biosciences, Kinimmune, Axioforce, and other start-ups. He has served as a board member, executive, and helped secure funding for these companies.

Cory and his wife Jodi are the parents of Cael, Ellie, Ava, Tate, and Jake, and attend the Crossing Church in Chesterfield.

Washington University Academic Page

“Potential Type 1 diabetes treatment may stem from outsmarting immune cells”